These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14601080)

  • 1. Gauging the impact of breast carcinoma screening in terms of tumor size and death rate.
    Michaelson JS; Satija S; Kopans D; Moore R; Silverstein M; Comegno A; Hughes K; Taghian A; Powell S; Smith B
    Cancer; 2003 Nov; 98(10):2114-24. PubMed ID: 14601080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.
    Blanchard K; Colbert JA; Puri D; Weissman J; Moy B; Kopans DB; Kaine EM; Moore RH; Halpern EF; Hughes KS; Tanabe KK; Smith BL; Michaelson JS
    Cancer; 2004 Aug; 101(3):495-507. PubMed ID: 15274062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening.
    Ernst MF; Voogd AC; Coebergh JW; Roukema JA
    Cancer; 2004 Apr; 100(7):1337-44. PubMed ID: 15042665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the survival of patients with breast carcinoma using tumor size.
    Michaelson JS; Silverstein M; Wyatt J; Weber G; Moore R; Halpern E; Kopans DB; Hughes K
    Cancer; 2002 Aug; 95(4):713-23. PubMed ID: 12209713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of breast carcinoma: what have we learned from screening?
    Tabár L; Duffy SW; Vitak B; Chen HH; Prevost TC
    Cancer; 1999 Aug; 86(3):449-62. PubMed ID: 10430253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gothenburg Breast Screening Trial.
    Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
    Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older.
    Freedman GM; Anderson PR; Goldstein LJ; Hanlon AL; Cianfrocca ME; Millenson MM; von Mehren M; Torosian MH; Boraas MC; Nicolaou N; Patchefsky AS; Evers K
    Cancer; 2003 Sep; 98(5):918-25. PubMed ID: 12942557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations.
    Ikeda DM; Andersson I; Wattsgård C; Janzon L; Linell F
    AJR Am J Roentgenol; 1992 Aug; 159(2):287-94. PubMed ID: 1632342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma.
    Tabar L; Tony Chen HH; Amy Yen MF; Tot T; Tung TH; Chen LS; Chiu YH; Duffy SW; Smith RA
    Cancer; 2004 Oct; 101(8):1745-59. PubMed ID: 15386334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tumor size and lymph node status on breast carcinoma lethality.
    Michaelson JS; Silverstein M; Sgroi D; Cheongsiatmoy JA; Taghian A; Powell S; Hughes K; Comegno A; Tanabe KK; Smith B
    Cancer; 2003 Nov; 98(10):2133-43. PubMed ID: 14601082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of the Swedish two-county program of mammographic screening for breast cancer.
    Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
    Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
    Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
    AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma.
    Zackrisson S; Andersson I; Manjer J; Janzon L
    Int J Cancer; 2004 Feb; 108(5):754-60. PubMed ID: 14696103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type of breast cancer diagnosis, screening, and survival.
    Cedolini C; Bertozzi S; Londero AP; Bernardi S; Seriau L; Concina S; Cattin F; Risaliti A
    Clin Breast Cancer; 2014 Aug; 14(4):235-40. PubMed ID: 24703317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.